These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15977926)

  • 41. Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism.
    Kovacs MJ; Anderson DA; Wells PS
    Pathophysiol Haemost Thromb; 2002; 32(3):131-3. PubMed ID: 12372927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. More Medicare patients eligible for home warfarin monitoring.
    Thompson CA
    Am J Health Syst Pharm; 2008 May; 65(9):800, 802. PubMed ID: 18436725
    [No Abstract]   [Full Text] [Related]  

  • 43. Acute GI bleeding in the setting of supratherapeutic international normalized ratio in patients taking warfarin: endoscopic diagnosis, clinical management, and outcomes.
    Rubin TA; Murdoch M; Nelson DB
    Gastrointest Endosc; 2003 Sep; 58(3):369-73. PubMed ID: 14528210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
    Rickles FR; Marder VJ
    J Thromb Haemost; 2005 May; 3(5):842-3. PubMed ID: 15869572
    [No Abstract]   [Full Text] [Related]  

  • 45. Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?
    Magagnoli M; Castagna L; Masci G; Santoro A
    Oncologist; 2004; 9(5):594-5; author reply 596. PubMed ID: 15477645
    [No Abstract]   [Full Text] [Related]  

  • 46. Sedation corner 25. The importance of the medical history questionnaire before conscious sedation.
    Roelofse J
    SADJ; 2008 May; 63(4):253. PubMed ID: 18689343
    [No Abstract]   [Full Text] [Related]  

  • 47. Patient case: impact of smoking cessation on international normalized ratio.
    Jordan SD; Stone MD; Alexander E; Haley J; McKee A
    J Pharm Pract; 2014 Oct; 27(5):470-3. PubMed ID: 24395009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Was there real deviation in this case?
    Avery JK
    J Ark Med Soc; 2004 Aug; 101(2):54-6. PubMed ID: 15318446
    [No Abstract]   [Full Text] [Related]  

  • 49. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral anticoagulation and mechanical heart valves: the case of the elderly and pregnancy.
    Rubboli A; Di Pasquale G
    Ital Heart J; 2005 May; 6(5):405-8. PubMed ID: 15934414
    [No Abstract]   [Full Text] [Related]  

  • 51. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
    Tay KH; Lip GY; Lane DA
    Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluating the interview in primary care medicine.
    Barsky AJ; Kazis LE; Freiden RB; Goroll AH; Hatem CJ; Lawrence RS
    Soc Sci Med Med Psychol Med Sociol; 1980 Dec; 14A(6):653-8. PubMed ID: 7209638
    [No Abstract]   [Full Text] [Related]  

  • 53. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader E; Martin N; Cohen G; Meyer M; Reiter P; Dimova A; Parikh D
    J Clin Pharm Ther; 2012 Aug; 37(4):375-7. PubMed ID: 22171554
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of a pharmacist-led warfarin self-management program on quality of life and anticoagulation control: a randomized trial.
    Verret L; Couturier J; Rozon A; Saudrais-Janecek S; St-Onge A; Nguyen A; Basmadjian A; Tremblay S; Brouillette D; de Denus S
    Pharmacotherapy; 2012 Oct; 32(10):871-9. PubMed ID: 23033226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Two sides of the warfarin issue: diligence versus potency.
    Rothschild BM; Helbing ME
    Am J Med; 2001 Jun; 110(8):672-4. PubMed ID: 11388344
    [No Abstract]   [Full Text] [Related]  

  • 56. [Fifty years of clinical use of warfarin].
    Quintero-González JA
    Invest Clin; 2010 Jun; 51(2):269-87. PubMed ID: 20928982
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cybermedicine: how computing empowers patients for better health care.
    Slack WV
    Stud Health Technol Inform; 1998; 52 Pt 1():3-5. PubMed ID: 10384407
    [No Abstract]   [Full Text] [Related]  

  • 58. Inhibition of warfarin anticoagulation associated with chelation therapy.
    Grebe HB; Gregory PJ
    Pharmacotherapy; 2002 Aug; 22(8):1067-9. PubMed ID: 12173793
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moderate dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? No.
    Khamashta MA; Hunt BJ
    J Thromb Haemost; 2005 May; 3(5):844-5. PubMed ID: 15869573
    [No Abstract]   [Full Text] [Related]  

  • 60. An audit of INR control in the Australian indigenous setting.
    Pickering A; Thomas DP
    Aust Fam Physician; 2007 Nov; 36(11):959-60, 967. PubMed ID: 18043786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.